Arvinas Inc (NASDAQ: ARVN) established initial surge of 0.53% at $9.46, as the Stock market unbolted on Wednesday, before settling in for the price of $9.41 at the close. Taking a more long-term approach, ARVN posted a 52-week range of $5.90-$29.61.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -5.32%. Meanwhile, its Annual Earning per share during the time was -5.32%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 61.67%. This publicly-traded company’s shares outstanding now amounts to $73.20 million, simultaneously with a float of $64.24 million. The organization now has a market capitalization sitting at $694.53 million.
Arvinas Inc (ARVN) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Arvinas Inc industry. Arvinas Inc’s current insider ownership accounts for 12.51%, in contrast to 91.62% institutional ownership. According to the most recent insider trade that took place on Sep 22 ’25, this organization’s Director bought 30,000 shares at the rate of 7.57, making the entire transaction reach 227,010 in total value, affecting insider ownership by 76,021. Preceding that transaction, on Jun 24 ’25, Company’s Chief Financial Officer sold 5,700 for 7.61, making the whole transaction’s value amount to 43,377. This particular insider is now the holder of 164,401 in total.
Arvinas Inc (ARVN) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.6 per share during the current fiscal year.
Arvinas Inc’s EPS increase for this current 12-month fiscal period is 61.67% and is forecasted to reach -3.16 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -3.07% through the next 5 years, which can be compared against the -5.32% growth it accomplished over the previous five years trading on the market.
Arvinas Inc (NASDAQ: ARVN) Trading Performance Indicators
Let’s observe the current performance indicators for Arvinas Inc (ARVN). It’s Quick Ratio in the last reported quarter now stands at 5.64. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.31.
In the same vein, ARVN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.08, a figure that is expected to reach -0.71 in the next quarter, and analysts are predicting that it will be -3.16 at the market close of one year from today.
